The identification of patients at highest risk for cardiovascular disease is important to all physicians. Nephrology practices, in general, are replete with patients who have glucose intolerance and ...

In patients with diabetes, strict glycemic control lowers the risk of cardiovascular events—which are the main cause of death in this setting 1 —and improves prognosis among those with chronic kidney ...

The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain. In this trial involving ...

The table shows multivariable-adjusted hazard ratios (95% confidence intervals) for diagnosed diabetes for different HbA1c levels. The hazard ratios for stroke were similar, but for all-cause ...

Individuals with chronic medical conditions may experience self-stigma, or negative beliefs, emotional reactions, and behaviors towards themselves as a result of their illness. New research published ...

Diabetes represents a serious global epidemic. Diabetes causes its own direct adverse effects but also predisposes patients to the development of both cardiovascular disease (CVD) and chronic kidney ...

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40. HealthDay News — The oral small-molecule glucagon-like peptide-1 receptor ...

Iron deficiency anaemia (IDA) is a prevalent condition with significant ramifications for diabetic care. Glycated haemoglobin (HbA1c) remains the cornerstone for monitoring long‐term glycaemic control ...

[Asia Economy Reporter Lee Gwan-joo] Although the majority of our citizens recognize diabetes as a 'serious disease,' a survey has revealed that they are not properly aware of 'glycated hemoglobin,' ...